{"id":136070,"date":"2019-01-23T04:22:05","date_gmt":"2019-01-23T04:22:05","guid":{"rendered":"http:\/\/www.georgianewsdesk.com\/news\/story\/136070\/global-cellbased-assay-market-expected-to-grow-at-9-cagr-between-2017-and-2025-market-insights-analysis-trends-and-forecast-sheer-analytics-and-insights.html"},"modified":"2019-01-23T04:22:05","modified_gmt":"2019-01-23T04:22:05","slug":"global-cellbased-assay-market-expected-to-grow-at-9-cagr-between-2017-and-2025-market-insights-analysis-trends-and-forecast-sheer-analytics-and-insights","status":"publish","type":"post","link":"http:\/\/www.honolulunewsnow.com\/news\/story\/136070\/global-cellbased-assay-market-expected-to-grow-at-9-cagr-between-2017-and-2025-market-insights-analysis-trends-and-forecast-sheer-analytics-and-insights.html","title":{"rendered":"Global cell-based assay market expected to grow at 9% CAGR between 2017 and 2025: Market insights, analysis, trends and forecast | Sheer Analytics and Insights"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
Global cell-based assay market analysis model<\/div>\n<\/div>\n<\/div>\n
The global Cell-Based Assay market is estimated to reach US$ 31.93Bn by the year 2025 while growing at a CAGR of 9% during the forecast period 2018-2025. Check latest market research report. Read more about the market here.<\/div>\n

Sheer Analytics and Insights Pvt. Ltd. has published a report on the global Cell-Based Assay market titled Global Cell-Based Assay Market<\/a><\/em> (By Product Type: Assay kits, Instruments, Reagents, Software and Services. By Application- Toxicology, ADME Studies and Drugs Discovery, By End-user- Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations and By Regions) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025.<\/em> The market is currently estimated to reach US$ 31.93Bn by the year 2025. The market is growing at a CAGR of 9% during the forecast period 2018-2025. The report covers the forecast and analysis of the Cell-Based Assay on both regional as well as global level.<\/p>\n

Download complete report here: <\/em><\/strong>https:\/\/www.sheeranalyticsandinsights.com\/market-report-research\/global-cell-based-assay-market-21<\/a> <\/em><\/p>\n

The rising incidents of chronic diseases coupled with high demand for throughput screening and drug discovery are the factors expected to drive the global cell-based assay market during the forecast period. Increasing investment towards developing new drugs and research programs from biotechnology companies are further estimated to create new necessities and augment the growth of the market over the forecast period. Pharmaceutical and biotechnology companies are continuously increasing their investment towards R&Ds for bringing out new innovations to fight against life-threatening diseases such as cancer, cardiovascular diseases, epilepsy, and others. This factor is expected to surge the demand for cell-based assay market. in addition, government grants and high competitions among the pharmaceutical and biotechnology companies to develop innovative solutions and drugs discovery are further expected to be the major reason responsible for the pharmaceutical and biotechnology companies segment to propel at a significant growth rate as compares other end-users.<\/p>\n

Geographically, the global Cell-Based Assay market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa. North America region holds the largest market share owing to the presence of technologically upgraded research institutes and established pharmaceutical companies, where the applications of cell-based assay are the most, as compared to other regions. Furthermore, high government initiatives and increased public spending towards the healthcare sector to reduce mortality rates from cancer is further estimated to be the prime factor responsible for North America to dominate the global market. The presence of established manufacturers of cell-based assays and their continuous efforts towards bringing the latest innovations is further expected to drive the cell-based assay market in this region. In addition, Asia-Pacific region is expected to grow at the fastest CAGR owing to the rising investments by the key market players of North America and Europe region across the developing nations of Asia Pacific region such as China, Japan, South Korea, and India. Fast-growing economies in the Asia-Pacific region and the rising awareness regarding the applications of cell-based assay is further expected to drive the Asia-Pacific cell-based assay market.<\/p>\n

In the recently published market research report by Sheer Analytics and Insights Pvt. Ltd., Cell-Based Assay market is segmented based on product type which is further divided into assay kits, instruments, reagents, software, and services. Based on application, the cell-based assay market has been segmented as toxicology, ADME studies, and drugs discovery. Furthermore, the market is segmented as end-user which is further sub-segmented as research institutes, pharmaceutical, and biotechnology companies and Contract Research Organizations.<\/p>\n

Download report sample here:<\/em><\/strong> https:\/\/www.sheeranalyticsandinsights.com\/request-sample\/2\/1\/206\/5<\/a> <\/em><\/p>\n

Taking a look at the recent market developments, Genocea partnered with Cofactor Genomics to provide the advanced assay module to facilitate the solid tumor patients with quick diagnosis and improved treatment method.<\/p>\n

Jessica Baker Flechtner, Chief Scientific Officer, Genocea., recently mentioned while talking to the Press, “We are working to develop truly effective personalized neoantigen vaccines with which to treat cancer patients. Through the exploration of advanced technologies like Cofactor’s ImmunoPrism assay, we aim to better understand the intra-tumoral immune responses we are eliciting in response to our vaccine,”<\/p>\n

According to David Messina, Chief Operating Officer, Cofactor Genomics,” Demonstrating the utility of a new approach to immune profiling is best accomplished with partners like Genocea, who are eager to gain access to the most innovative and advanced assays.”<\/p>\n

Some of the key industry players in the global Cell-Based Assay market include Cell Biolabs, Inc., Dickinson and Company, Enzo Life Sciences, Inc., Essen BioScience Inc., Lonza Group, MDB Biosciences, Merck KGaA, PerkinElmer Inc., Selexis SA, and Thermo Fisher Scientific.<\/p>\n

Global Cell-Based Assay Market: By Product Type<\/strong><\/p>\n